75/100B47.010
USD
0.10
(0.21%)
Pre Open·48.030USD+1.020(+2.17%)
Last updated: · Delayed 15 min
Fair value82.55Plus-43%62Price 47.01103
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Sanofi ADS stock buybacks 1999–2026What are stock buybacks? A stock buyback is a company buying its own shares on the market. With fewer shares left, each remaining share owns a bigger part of the company.
Sanofi ADS spent 1.18B EUR buying back its shares in Q2 FY2026, the three months to 30 June 2026, with no change to compare on the same quarter a year before. Sanofi ADS spent 5.68B EUR buying back its shares in fiscal year 2025, up 1,779.7% on the year before.
Last updated 9 Nov 2026 · Next report 4 Feb 2027
Stock buybacks
Growth
| Fiscal year | Period ending | Stock buybacks | Growth | Dividends paid | Free cash flow |
|---|---|---|---|---|---|
| TTM | 30 Jun 2026 | — | — | — | — |
| FY2025 | 31 Dec 2025 | 5.68B | +1,779.72% | 5.39B | 10.14B |
| FY2024 | 31 Dec 2024 | 302.00M | -49.07% | 4.70B | 5.89B |
| FY2023 | 31 Dec 2023 | 593.00M | +19.32% | 4.45B | 7.35B |
| FY2022 | 31 Dec 2022 | 497.00M | +30.10% | 4.17B | 8.42B |
| FY2021 | 31 Dec 2021 | 382.00M | -53.53% | 4.01B | 8.48B |
| FY2020 | 31 Dec 2020 | 822.00M | +9,033.33% | 3.94B | 5.34B |
| FY2019 | 31 Dec 2019 | 9.00M | -99.18% | 3.83B | 5.93B |
| FY2018 | 31 Dec 2018 | 1.10B | -49.07% | 3.77B | 3.57B |
| FY2017 | 31 Dec 2017 | 2.16B | -25.65% | 3.71B | 5.42B |
| FY2016 | 31 Dec 2016 | 2.91B | +63.00% | 3.76B | 5.76B |
| FY2015 | 31 Dec 2015 | 1.78B | -0.94% | 3.69B | 6.15B |
| FY2014 | 31 Dec 2014 | 1.80B | +9.75% | 3.68B | 6.13B |
| FY2013 | 31 Dec 2013 | 1.64B | +99.39% | 3.64B | 5.56B |
| FY2012 | 31 Dec 2012 | 823.00M | -23.37% | 3.49B | 6.56B |
| FY2011 | 31 Dec 2011 | 1.07B | +234.58% | 1.37B | 7.54B |
| FY2010 | 31 Dec 2010 | 321.00M | — | 3.13B | 8.19B |
| FY2009 | 31 Dec 2009 | 0.00 | -100.00% | 2.87B | 6.73B |
| FY2008 | 31 Dec 2008 | 1.23B | -32.06% | 2.70B | 6.92B |
| FY2007 | 31 Dec 2007 | 1.81B | — | 2.36B | 5.50B |
| FY2006 | 31 Dec 2006 | 0.00 | — | 2.04B | 5.15B |
| FY2005 | 31 Dec 2005 | 0.00 | — | 1.60B | 5.25B |
| FY2004 | 31 Dec 2004 | 0.00 | -100.00% | 731.00M | 4.03B |
| FY2003 | 31 Dec 2003 | 1.00B | -14.51% | 581.23M | 1.89B |
| FY2002 | 31 Dec 2002 | 1.17B | +618.53% | 476.49M | 272.55M |
| FY2001 | 31 Dec 2001 | 163.00M | -10.93% | 323.00M | 1.25B |
| FY2000 | 31 Dec 2000 | 183.00M | — | 241.00M | 827.00M |
| FY1999 | 31 Dec 1999 | 0.00 | — | 178.00M | 414.00M |
| Quarter | Period ending | Stock buybacks | Growth on a year before | Dividends paid | Free cash flow |
|---|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | 1.18B | — | 5.74B | 3.90B |
| Q1 FY2026 | 31 Mar 2026 | 0.00 | — | 0.00 | 1.68B |
| Q4 FY2025 | 31 Dec 2025 | 0.00 | — | 0.00 | 1.59B |
| Q3 FY2025 | 30 Sept 2025 | 29.00M | — | 0.00 | — |
| Q2 FY2025 | 30 Jun 2025 | 0.00 | -100.00% | 0.00 | 0.00 |
| Q1 FY2025 | 31 Mar 2025 | 0.00 | — | 0.00 | 2.09B |
| Q4 FY2024 | 31 Dec 2024 | 0.00 | -100.00% | 0.00 | 0.00 |
| Q3 FY2024 | 30 Sept 2024 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2024 | 30 Jun 2024 | 326.42M | -16.78% | 5.08B | -412.89M |
| Q1 FY2024 | 31 Mar 2024 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2023 | 31 Dec 2023 | 230.00M | +108.19% | 0.00 | 4.59B |
| Q3 FY2023 | 30 Sept 2023 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2023 | 30 Jun 2023 | 392.25M | -0.25% | 4.81B | 2.85B |
| Q1 FY2023 | 31 Mar 2023 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2022 | 31 Dec 2022 | 110.48M | -59.77% | 328.47M | 5.32B |
| Q3 FY2022 | 30 Sept 2022 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2022 | 30 Jun 2022 | 393.22M | +133.08% | 4.55B | 3.11B |
| Q1 FY2022 | 31 Mar 2022 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2021 | 31 Dec 2021 | 274.64M | -40.43% | 178.22M | 4.57B |
| Q3 FY2021 | 30 Sept 2021 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2021 | 30 Jun 2021 | 168.71M | -53.27% | 4.83B | 4.50B |
| Q1 FY2021 | 31 Mar 2021 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2020 | 31 Dec 2020 | 461.00M | +15,266.67% | 0.00 | 1.98B |
| Q3 FY2020 | 30 Sept 2020 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2020 | 30 Jun 2020 | 361.00M | — | 3.94B | 3.24B |
| Q1 FY2020 | 31 Mar 2020 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2019 | 31 Dec 2019 | 3.00M | — | 0.00 | 3.59B |
| Q3 FY2019 | 30 Sept 2019 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2019 | 30 Jun 2019 | 0.00 | — | 0.00 | 0.00 |
| Q1 FY2019 | 31 Mar 2019 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2018 | 31 Dec 2018 | 0.00 | — | 0.00 | 0.00 |
| Q3 FY2018 | 30 Sept 2018 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2018 | 30 Jun 2018 | 0.00 | — | 0.00 | 0.00 |
| Q1 FY2018 | 31 Mar 2018 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2017 | 31 Dec 2017 | 0.00 | — | 0.00 | 0.00 |
| Q3 FY2017 | 30 Sept 2017 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2017 | 30 Jun 2017 | 0.00 | — | 0.00 | 0.00 |
| Q1 FY2017 | 31 Mar 2017 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2016 | 31 Dec 2016 | 0.00 | — | 0.00 | 0.00 |
| Q3 FY2016 | 30 Sept 2016 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2016 | 30 Jun 2016 | 0.00 | — | 0.00 | 0.00 |
| Q1 FY2016 | 31 Mar 2016 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2015 | 31 Dec 2015 | 0.00 | — | 0.00 | 0.00 |
| Q3 FY2015 | 30 Sept 2015 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2015 | 30 Jun 2015 | 0.00 | — | 0.00 | 0.00 |
| Q1 FY2015 | 31 Mar 2015 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2014 | 31 Dec 2014 | 0.00 | — | 0.00 | 0.00 |
| Q3 FY2014 | 30 Sept 2014 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2014 | 30 Jun 2014 | 0.00 | — | 0.00 | 0.00 |
| Q1 FY2014 | 31 Mar 2014 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2013 | 31 Dec 2013 | 0.00 | — | 0.00 | 0.00 |
| Q3 FY2013 | 30 Sept 2013 | 0.00 | — | 0.00 | 0.00 |
| Q2 FY2013 | 30 Jun 2013 | 0.00 | — | 0.00 | 0.00 |
| Q1 FY2013 | 31 Mar 2013 | 0.00 | — | 0.00 | 0.00 |
| Q4 FY2012 | 31 Dec 2012 | 0.00 | — | 0.00 | 0.00 |
| Q3 FY2012 | 30 Sept 2012 | 0.00 | — | 0.00 | 0.00 |
Figures in EUR. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
The money spent buying back the company's own shares in each period, from the cash flow statement.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow
Common questions about Sanofi ADS's buybacks
Source: Financial Modeling Prep